BSL — Raffles Medical Cashflow Statement
0.000.00%
Last trade - 00:00- SG$1.84bn
- SG$1.61bn
- SG$765.30m
Annual cashflow statement for Raffles Medical, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 83.7 | 144 | 91.1 | 62.3 | 71.1 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 44.6 | 74.3 | 20.5 | 28 | 19.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -7.57 | -62 | 39.4 | -47.1 | -34.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 160 | 196 | 189 | 86.3 | 101 |
| Capital Expenditures | -52.8 | -25.3 | -21.9 | -20.9 | -10 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.605 | 2.47 | 9.53 | 11 | 7.52 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -52.2 | -22.8 | -12.4 | -9.87 | -2.5 |
| Financing Cash Flow Items | -7.3 | -6.8 | -5.12 | -6.6 | -20.6 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -46.9 | -184 | -85.5 | -76.2 | -131 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 61.9 | -11.9 | 90.5 | 1.13 | -32.9 |